Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 62Recruiting 59Completed 40Not yet recruiting 27Active not recruiting 15Withdrawn 9Terminated 5Enrolling by invitation 3Suspended 2

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 2Stomach Neoplasms 1Liver Neoplasms 1

Interventions

Drug Therapy 4Cisplatin 4Chemoradiotherapy 4lenvatinib 3camrelizumab 3Specimen Handling 3Paclitaxel 3Oxaliplatin 3Carboplatin 3toripalimab 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy 2Patient Navigation 2Methods 2Leucovorin 2Laparoscopy 2Fluorouracil 2Fluorodeoxyglucose F18 2Educational Status 2Early Intervention, Educational 2Capecitabine 2Biopsy 2Bevacizumab 2130-nm albumin-bound paclitaxel 2tislelizumab 1sintilimab 1pembrolizumab 1nimotuzumab 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × lenvatinib × Gastrointestinal × Clear all
NCT07356466 2026-01-21

FUGES032

Fujian Medical University

Phase EARLY_PHASE1 Enrolling by invitation
100 enrolled
Gastrointestinal

Stomach Neoplasms

NCT07052448 2025-07-04

The Efficacy of Sequential RT After Triple Therapy for uHCC

Fujian Provincial Hospital

Enrolling by invitation
35 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05171335 2022-09-21

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

The Methodist Hospital Research Institute

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡